| UniProt ID | FA11_HUMAN | |
|---|---|---|
| UniProt AC | P03951 | |
| Protein Name | Coagulation factor XI | |
| Gene Name | F11 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 625 | |
| Subcellular Localization | Secreted. | |
| Protein Description | Factor XI triggers the middle phase of the intrinsic pathway of blood coagulation by activating factor IX.. | |
| Protein Sequence | MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 5 | Phosphorylation | ---MIFLYQVVHFIL ---CCHHHHHHHHHH | 6.63 | 24043423 | |
| 14 | Phosphorylation | VVHFILFTSVSGECV HHHHHHHHCCCCHHH | 25.44 | 24043423 | |
| 15 | Phosphorylation | VHFILFTSVSGECVT HHHHHHHCCCCHHHH | 13.62 | 24043423 | |
| 17 | Phosphorylation | FILFTSVSGECVTQL HHHHHCCCCHHHHHH | 28.74 | 22817900 | |
| 22 | Phosphorylation | SVSGECVTQLLKDTC CCCCHHHHHHHHHHC | 25.76 | 22817900 | |
| 75 | Phosphorylation | EDPTRWFTCVLKDSV CCCCCEEEEEEECCH | 8.51 | 23532336 | |
| 81 | Phosphorylation | FTCVLKDSVTETLPR EEEEEECCHHHCCCC | 29.38 | 23532336 | |
| 90 | N-linked_Glycosylation | TETLPRVNRTAAISG HHCCCCCCCCHHHCC | 36.54 | 25092234 | |
| 104 (in isoform 2) | Phosphorylation | - | 18.88 | 28450419 | |
| 108 (in isoform 2) | Phosphorylation | - | 21.87 | 28450419 | |
| 115 | Phosphorylation | SACNKDIYVDLDMKG HCCCCCEEEEEECCC | 9.69 | 18491316 | |
| 125 | Phosphorylation | LDMKGINYNSSVAKS EECCCCCCCHHHHHH | 17.94 | 18491316 | |
| 126 | N-linked_Glycosylation | DMKGINYNSSVAKSA ECCCCCCCHHHHHHH | 24.26 | 17623646 | |
| 126 | N-linked_Glycosylation | DMKGINYNSSVAKSA ECCCCCCCHHHHHHH | 24.26 | 25092234 | |
| 128 | Phosphorylation | KGINYNSSVAKSAQE CCCCCCHHHHHHHHH | 23.58 | 18491316 | |
| 163 | N-linked_Glycosylation | FPSLEHRNICLLKHT CCCCCCCCEEEEEEC | 31.09 | 25092234 | |
| 180 | Acetylation | GTPTRITKLDKVVSG CCCCEEEHHHHHHCC | 52.93 | 7396797 | |
| 186 | Phosphorylation | TKLDKVVSGFSLKSC EHHHHHHCCCCHHHH | 36.79 | - | |
| 347 | Phosphorylation | NEGKGKCYLKLSSNG CCCCCEEEEEECCCC | 15.45 | 28270605 | |
| 351 | Phosphorylation | GKCYLKLSSNGSPTK CEEEEEECCCCCCCE | 21.85 | 28270605 | |
| 352 | Phosphorylation | KCYLKLSSNGSPTKI EEEEEECCCCCCCEE | 56.50 | 28270605 | |
| 353 | N-linked_Glycosylation | CYLKLSSNGSPTKIL EEEEECCCCCCCEEE | 52.14 | UniProtKB CARBOHYD | |
| 355 | Phosphorylation | LKLSSNGSPTKILHG EEECCCCCCCEEEEC | 33.38 | 28270605 | |
| 357 | Phosphorylation | LSSNGSPTKILHGRG ECCCCCCCEEEECCC | 32.20 | 28270605 | |
| 370 | Phosphorylation | RGGISGYTLRLCKMD CCCCCCEEEEEEECC | 14.66 | 24719451 | |
| 394 | Phosphorylation | RIVGGTASVRGEWPW EEECCCEEECCCCCC | 16.51 | - | |
| 450 | N-linked_Glycosylation | RVYSGILNQSEIKED HEEECCCCHHHHCCC | 41.22 | 19159218 | |
| 488 | Phosphorylation | IALLKLETTVNYTDS EEEEEEEEEECCCCC | 46.62 | 29978859 | |
| 489 | Phosphorylation | ALLKLETTVNYTDSQ EEEEEEEEECCCCCC | 9.44 | 29978859 | |
| 491 | N-linked_Glycosylation | LKLETTVNYTDSQRP EEEEEEECCCCCCCC | 31.71 | 1998667 | |
| 492 | Phosphorylation | KLETTVNYTDSQRPI EEEEEECCCCCCCCE | 13.95 | 29978859 | |
| 493 | Phosphorylation | LETTVNYTDSQRPIC EEEEECCCCCCCCEE | 24.78 | 29978859 | |
| 495 | Phosphorylation | TTVNYTDSQRPICLP EEECCCCCCCCEECC | 21.93 | 29978859 | |
| 503 | Phosphorylation | QRPICLPSKGDRNVI CCCEECCCCCCCCEE | 36.00 | 24719451 | |
| 517 | Phosphorylation | IYTDCWVTGWGYRKL EEEECEECCCHHHHH | 11.61 | - | |
| 521 | Phosphorylation | CWVTGWGYRKLRDKI CEECCCHHHHHHHHH | 9.69 | - | |
| 531 | Phosphorylation | LRDKIQNTLQKAKIP HHHHHHHHHHHCCCC | 17.75 | 26699800 | |
| 608 | Phosphorylation | QRERPGVYTNVVEYV CCCCCCCEEHHHHHH | 9.86 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FA11_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 163 | N | Glycosylation |
| 25092234 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FA11_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| A4_HUMAN | APP | physical | 28514442 | |
| CREL2_HUMAN | CRELD2 | physical | 28514442 | |
| N42L2_HUMAN | N4BP2L2 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 612416 | Factor XI deficiency (FA11D) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-450 AND ASN-491, AND MASSSPECTROMETRY. | |
| "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-126; ASN-450 AND ASN-491,AND MASS SPECTROMETRY. | |
| "Location of the disulfide bonds in human coagulation factor XI: thepresence of tandem apple domains."; McMullen B.A., Fujikawa K., Davie E.W.; Biochemistry 30:2056-2060(1991). Cited for: PARTIAL PROTEIN SEQUENCE, AND DISULFIDE BONDS. | |
| Phosphorylation | |
| Reference | PubMed |
| "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17 AND THR-22, AND MASSSPECTROMETRY. | |